Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 Study of SCB0020160 in Healthy Adult Males
NCT07682337Phase 1Not yet recruiting
- Sponsor
- SCbio
- Start
- Jun 2026
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in solid tumor, obesity and idiopathic pulmonary fibrosis (IPF) comparing SCB0020160 with Placebo (2 arms). Primary endpoints: Incidence and frequency of adverse events, Physical examination findings and 11 more. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
SCB0020160
03
Conditions
solid tumorobesityidiopathic pulmonary fibrosis (IPF)
Beyond the preview
Go deeper on NCT07682337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07682337.